New Russian Trivalent Hepatitis B Vaccine (Bubo®-Unigep): Phase I Clinical Study Results and Perspectives of Further Investigations Aiming Registration in Russia

Epidemiology and Vaccinal Prevention
doi 10.31631/2073-3046-2019-18-6-45-52
Full Text
Abstract

Available in full text

Date
Authors
Publisher

LLC Numicom

Related search

Phase I Clinical Evaluation of Seasonal Influenza Hemagglutinin (HA) DNA Vaccine Prime Followed by Trivalent Influenza Inactivated Vaccine (IIV3) Boost

Contemporary Clinical Trials
MedicinePharmacology
2015English

Cytomegalovirus Vaccine: Phase II Clinical Trial Results

Clinical Microbiology and Infection
MedicineInfectious DiseasesMicrobiology
2014English

Further Investigations on Some Results of Yu

Journal of Classical Analysis
2019English

Quadrivalent Versus Trivalent Influenza Vaccine: Clinical Outcomes in Two Influenza Seasons, Historical Cohort Study

Clinical Microbiology and Infection
MedicineInfectious DiseasesMicrobiology
2020English

Knowledge and Acceptance of Hepatitis B Vaccine

The Internet Journal of Healthcare Administration
2004English

Challenge With Hepatitis B Vaccine in Children Previously Vaccinated With a Hepatitis B-Containing Combination Vaccine

Advances in Therapy
MedicinePharmacology
2010English

Immunogenicity, Safety and Consistency of New Trivalent Inactivated Influenza Vaccine

Vaccine
Molecular MedicinePublic HealthVeterinaryMicrobiology EnvironmentalImmunologyInfectious DiseasesOccupational Health
2008English

Knowledge and Behaviors Toward Hepatitis B and the Hepatitis B Vaccine in the Laotian Community in Minnesota

Journal of Immigrant and Minority Health
EnvironmentalPublic HealthEpidemiologyOccupational Health
2013English

Safety and Immunogenicity of Hepatitis B Vaccine: A Study on Iranian Navy Personnel

Vaccine Research
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy